Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record no longer displays the 2019 NIH grant/contract identifier, and the site revision label changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-19T14:19:32.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical trial record for the completed Phase 2 VIS649 study in IgA nephropathy is displayed, including study details, results, participant criteria, and supporting documents.
    Difference
    100%
    Check dated 2026-11-12T14:27:31.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-29T14:41:09.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-22T15:22:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-15T14:33:04.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The revision label in the site footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-08T15:35:54.000Z thumbnail image

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.